← Leaderboards
Karin N Westlund-High
Albuquerque Va Medical Center
$6,690,959
Attributed
$8,186,286
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,186,286 · 8
VA$0 · 3
By mechanism
R01$4,805,729 · 1
U01$1,483,588 · 1
UG3$1,076,942 · 1
R21$579,125 · 2
K18$137,377 · 1
P01$103,525 · 2
Top collaborators
- Sascha R Alles2 shared
- Adinarayana Kunamneni2 shared
- George R Uhl1 shared
Others in their field
Top investigators on “Pain”
- Emer Leahy · Psychogenics, Inc.$49,781,254
- Lynn Larson Debar · Kaiser Foundation Research Institute$37,527,482
- J Richard Landis · University Of Pennsylvania$34,799,488
- Clifford J Woolf · Boston Children'S Hospital$30,992,766
- Emeran A Mayer · University Of California Los Angeles$29,229,798
- Pamela Susan Douglas · Duke University$28,862,172
Research focus
PainChronicNeuronsBrainChronic PainCellsReceptorAcuteBehavioralRattusFuturePainful NeuropathyAnxietyBehaviorSignal TransductionAnalgesicsNerve InjuryDoseResponsePancreatitisMechanicsNerveCentral SensitizationBase
Grant awards (38)
Advancing Development of Novel Immunotherapy for Chemotherapy-induced Peripheral Neuropathy (CIPN)$0
I01 · FY2024 · VA · contact PI
Modulating Pain Generators of Chronic Trigeminal Neuropathic Pain$0
I01 · FY2024 · VA · contact PI
Advancing Development of Novel Immunotherapy for Chemotherapy-induced Peripheral Neuropathy (CIPN)$0
I01 · FY2023 · VA · contact PI
Modulating Pain Generators of Chronic Trigeminal Neuropathic Pain$0
I01 · FY2023 · VA · contact PI
Neuroimmune mechanisms of a humanized CCK-B receptor scFv as therapy for chronic pain patients$77,837
UG3 · FY2022 · NS · contact PI
Modulating Pain Generators of Chronic Trigeminal Neuropathic Pain$0
I01 · FY2022 · VA · contact PI
PTPRD ligands for stimulant and opiate use disorders$1,483,588
U01 · FY2021 · DA · contact PI
Development of a CCKBR-targeting scFv as Therapy for Chronic Pain Patients$999,105
UG3 · FY2021 · NS · contact PI
ShEEP Request for Biotek Cytation 5 Imaging System$0
IS1 · FY2021 · VA · contact PI
Modulating Pain Generators of Chronic Trigeminal Neuropathic Pain$0
I01 · FY2021 · VA · contact PI
scFv Antibody Therapy for Chronic Trigeminal Neuropathic Pain$189,625
R21 · FY2020 · DE · contact PI
scFv Antibody Therapy for Chronic Trigeminal Neuropathic Pain$240,500
R21 · FY2019 · DE · contact PI
Peripheral and Central Pain Generators of Chronic Trigeminal Neuropathic Pain$0
I01 · FY2019 · VA · contact PI
Peripheral and Central Pain Generators of Chronic Trigeminal Neuropathic Pain$0
I01 · FY2018 · VA · contact PI
Peripheral and Central Pain Generators of Chronic Trigeminal Neuropathic Pain$0
I01 · FY2017 · VA · contact PI
Peripheral and Central Pain Generators of Chronic Trigeminal Neuropathic Pain$0
I01 · FY2016 · VA · contact PI
Neurogenic Amplification of Pancreatitis Pain$426,283
R01 · FY2014 · NS · contact PI
Neurogenic Amplification of Pancreatitis Pain$415,513
R01 · FY2013 · NS · contact PI
Neurogenic Amplification of Pancreatitis Pain$449,754
R01 · FY2012 · NS · contact PI
Neurogenic Amplification of Pancreatitis Pain$455,585
R01 · FY2011 · NS · contact PI
Physiological and Emotional Reactivity to Pain after Physical and Sexual Abuse$137,377
K18 · FY2011 · DE · contact PI
Neurogeneic Amplification of Pancreatitis Pain$56,000
R01 · FY2009 · NS · contact PI
Neurogeneic Amplification of Pancreatitis Pain$10,443
R01 · FY2009 · NS · contact PI
Neurogeneic Amplification of Pancreatitis Pain$351,936
R01 · FY2008 · NS · contact PI
Neurogeneic Amplification of Pancreatitis Pain$351,925
R01 · FY2007 · NS · contact PI
Neurogeneic Amplification of Pancreatitis Pain$302,864
R01 · FY2006 · NS · contact PI
Neurogeneic Amplification of Pancreatitis Pain$59,145
R01 · FY2006 · NS · contact PI
Neurogeneic Amplification of Pancreatitis Pain$359,925
R01 · FY2005 · NS
Neurogeneic Amplification of Pancreatitis Pain$349,443
R01 · FY2004 · NS
NEUROGENIC AMPLIFICATION OF PANCREATITIS PAIN$298,000
R01 · FY2003 · NS
NEUROGENIC AMPLIFICATION OF PANCREATITIS PAIN$298,000
R01 · FY2002 · NS
Glutamate Induced Molecular Events Contributing to Chro*$74,500
R21 · FY2002 · AR
NEUROGENIC CONTRIBUTIONS TO CHRONIC ARTHRITIS$0
P01 · FY2002 · NS
NEUROGENIC AMPLIFICATION OF PANCREATITIS PAIN$298,000
R01 · FY2001 · NS
Glutamate Induced Molecular Events$74,500
R21 · FY2001 · AR
NEUROGENIC CONTRIBUTIONS TO CHRONIC ARTHRITIS$0
P01 · FY2001 · NS
NEUROGENIC AMPLIFICATION OF PANCREATITIS PAIN$322,913
R01 · FY2000 · NS
VISCERAL PAIN$103,525
P01 · FY2000 · NS